CEFDINIR

CEFDINIR was reported 7727 times

CEFDINIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 33 0.0311
1 PORTAL VENOUS GAS 11 0.0303
2 SYRINGOMYELIA 7 0.0252
3 REBOUND ACID HYPERSECRETION 67 0.0221
4 HYPERPARATHYROIDISM SECONDARY 55 0.0219
5 NEPHROGENIC ANAEMIA 92 0.0198
6 VANISHING BILE DUCT SYNDROME 18 0.0161
7 DERMATITIS DIAPER 11 0.0156
8 PERINEAL ABSCESS 5 0.0111
9 PNEUMONIA HAEMOPHILUS 5 0.0103
10 SERUM SICKNESS-LIKE REACTION 6 0.0095
11 UPPER RESPIRATORY TRACT INFLAMMATION 10 0.0083
12 END STAGE RENAL DISEASE 149 0.0082
13 OTITIS MEDIA ACUTE 6 0.0082
14 INFUSION SITE DISCHARGE 14 0.0080
15 INFUSION SITE MASS 8 0.0074
16 INFUSION SITE NODULE 7 0.0073
17 INFUSION SITE BRUISING 14 0.0065
18 ADENOCARCINOMA GASTRIC 6 0.0065
19 CHRONIC KIDNEY DISEASE 485 0.0064
20 CROUP INFECTIOUS 5 0.0063
21 ESSENTIAL HYPERTENSION 11 0.0060
22 TYMPANIC MEMBRANE PERFORATION 10 0.0059
23 INFECTED BITE 5 0.0059
24 MYCOTIC ALLERGY 5 0.0058
25 INFUSION SITE HAEMORRHAGE 19 0.0058
26 OBSTRUCTIVE SLEEP APNOEA SYNDROME 8 0.0055
27 PNEUMONIA STREPTOCOCCAL 6 0.0055
28 CERUMEN IMPACTION 5 0.0055
29 DRY AGE-RELATED MACULAR DEGENERATION 6 0.0054
30 RECALLED PRODUCT ADMINISTERED 51 0.0053
31 MULTIPLE ALLERGIES 41 0.0052
32 MASTOIDITIS 5 0.0051
33 SERUM SICKNESS 14 0.0050
34 CHOLESTATIC LIVER INJURY 11 0.0049
35 INFUSION SITE DISCOMFORT 5 0.0048
36 EAR INFECTION 123 0.0046
37 ECONOMIC PROBLEM 70 0.0046
38 INFUSION SITE SWELLING 28 0.0044
39 RHONCHI 6 0.0043
40 PNEUMONIA INFLUENZAL 5 0.0042
41 INFUSION SITE PRURITUS 13 0.0041
42 MIDDLE EAR EFFUSION 9 0.0041
43 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 22 0.0040
44 OTITIS MEDIA 13 0.0039
45 INFUSION SITE ERYTHEMA 33 0.0039
46 PNEUMONIA PSEUDOMONAL 6 0.0039
47 CLOSTRIDIAL INFECTION 13 0.0038
48 BODY TEMPERATURE ABNORMAL 7 0.0038
49 URINARY BLADDER HAEMORRHAGE 8 0.0038
50 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 5 0.0038
51 TONSILLECTOMY 6 0.0036
52 ECHOCARDIOGRAM ABNORMAL 5 0.0036
53 SINUSITIS 364 0.0035
54 PELVIC VENOUS THROMBOSIS 5 0.0035
55 BLOOD CHLORIDE INCREASED 6 0.0035
56 RENAL INJURY 103 0.0035
57 STREPTOCOCCAL INFECTION 19 0.0034
58 SINUS OPERATION 8 0.0034
59 INFUSION SITE PAIN 43 0.0033
60 PHARYNGITIS STREPTOCOCCAL 36 0.0033
61 SEASONAL ALLERGY 47 0.0033
62 THROMBOPHLEBITIS SUPERFICIAL 10 0.0033
63 FAECES DISCOLOURED 70 0.0032
64 CHRONIC SINUSITIS 12 0.0032
65 PROTEIN TOTAL DECREASED 12 0.0032
66 CLOSTRIDIUM TEST POSITIVE 7 0.0032
67 TUBULOINTERSTITIAL NEPHRITIS 59 0.0031
68 RHINITIS ALLERGIC 14 0.0031
69 PANCREATIC CYST 6 0.0031
70 NASAL SEPTUM DEVIATION 6 0.0031
71 ABSCESS LIMB 13 0.0030
72 RENAL TUBULAR NECROSIS 29 0.0030
73 EXPOSURE TO SARS-COV-2 5 0.0029
74 ANHEDONIA 77 0.0029
75 MILIARIA 5 0.0029
76 PARANASAL SINUS DISCOMFORT 11 0.0029
77 ACUTE SINUSITIS 5 0.0029
78 PHARYNGEAL ERYTHEMA 6 0.0028
79 CLOSTRIDIUM DIFFICILE COLITIS 30 0.0028
80 CARDIAC ABLATION 5 0.0028
81 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24 0.0028
82 CANCER PAIN 7 0.0027
83 VIRAL UPPER RESPIRATORY TRACT INFECTION 13 0.0027
84 INFUSION SITE EXTRAVASATION 17 0.0027
85 RENAL FAILURE 362 0.0027
86 SCREAMING 17 0.0027
87 UPPER RESPIRATORY TRACT INFECTION 122 0.0026
88 PANCREATITIS NECROTISING 6 0.0026
89 CLOSTRIDIUM DIFFICILE INFECTION 57 0.0026
90 RESPIRATORY TRACT INFECTION 67 0.0026
91 PRE-EXISTING CONDITION IMPROVED 16 0.0026
92 NECROTISING FASCIITIS 9 0.0026
93 PNEUMONIA STAPHYLOCOCCAL 5 0.0025
94 OXYGEN CONSUMPTION INCREASED 6 0.0025
95 PNEUMONIA BACTERIAL 23 0.0025
96 HAEMATOLOGICAL INFECTION 6 0.0025
97 CATHETER SITE HAEMORRHAGE 6 0.0024
98 GASTROENTERITIS VIRAL 43 0.0024
99 EYE CONTUSION 5 0.0024
100 NEPHROPATHY 22 0.0024
101 INFUSION SITE REACTION 7 0.0023
102 CONJUNCTIVAL HYPERAEMIA 8 0.0022
103 COMPUTERISED TOMOGRAM ABNORMAL 5 0.0022
104 SINUS HEADACHE 13 0.0022
105 NECK SURGERY 5 0.0021
106 ACUTE KIDNEY INJURY 326 0.0021
107 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
108 AUTOIMMUNE THYROIDITIS 8 0.0021
109 PANCREATIC CARCINOMA METASTATIC 6 0.0021
110 DERMATITIS CONTACT 24 0.0021
111 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
112 PARANASAL SINUS HYPERSECRETION 8 0.0021
113 HYPERTONIC BLADDER 6 0.0021
114 LYMPHADENITIS 5 0.0021
115 EAR PAIN 40 0.0021
116 RHINOVIRUS INFECTION 8 0.0021
117 BRONCHITIS 152 0.0021
118 OSTEOPENIA 31 0.0020
119 EYE INFECTION 23 0.0020
120 ATYPICAL PNEUMONIA 6 0.0020
121 FUNGAL SKIN INFECTION 8 0.0020
122 SINUS DISORDER 39 0.0020
123 ATELECTASIS 19 0.0020
124 CYSTITIS 62 0.0019
125 CHOLECYSTITIS CHRONIC 13 0.0019
126 FAILURE TO THRIVE 10 0.0019
127 BLOOD CREATININE DECREASED 6 0.0019
128 SKIN ABRASION 9 0.0019
129 ARTHROPOD BITE 14 0.0019
130 PNEUMONIA VIRAL 6 0.0019
131 AORTIC VALVE INCOMPETENCE 8 0.0019
132 ANIMAL BITE 5 0.0019
133 DECREASED ACTIVITY 20 0.0019
134 EAR CONGESTION 5 0.0018
135 ABDOMINAL RIGIDITY 5 0.0018
136 LARGE INTESTINAL ULCER 5 0.0018
137 URINARY TRACT INFECTION 313 0.0018
138 RESPIRATORY TRACT CONGESTION 29 0.0018
139 ERYTHEMA MULTIFORME 17 0.0018
140 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
141 MUCOUS STOOLS 9 0.0018
142 LYME DISEASE 6 0.0018
143 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
144 BLOOD ALBUMIN DECREASED 14 0.0018
145 VASCULAR DEVICE INFECTION 8 0.0018
146 STEVENS-JOHNSON SYNDROME 39 0.0018
147 OBSTRUCTION 7 0.0018
148 KIDNEY INFECTION 34 0.0017
149 EYELID MARGIN CRUSTING 5 0.0017
150 HOSPICE CARE 17 0.0017
151 PERIPHERAL VENOUS DISEASE 7 0.0017
152 BRONCHIOLITIS 6 0.0017
153 HYPERURICAEMIA 7 0.0017
154 ACIDOSIS 13 0.0017
155 PHARYNGITIS 21 0.0017
156 IMPAIRED GASTRIC EMPTYING 23 0.0017
157 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
158 TOOTH INFECTION 21 0.0016
159 VIRAL INFECTION 53 0.0016
160 PRODUCTIVE COUGH 76 0.0016
161 CHOLECYSTITIS ACUTE 9 0.0016
162 SPUTUM DISCOLOURED 15 0.0016
163 INSURANCE ISSUE 24 0.0016
164 FOOD ALLERGY 12 0.0016
165 PERIPHERAL VASCULAR DISORDER 8 0.0016
166 CARDIAC FLUTTER 10 0.0015
167 FULL BLOOD COUNT DECREASED 31 0.0015
168 PNEUMONIA FUNGAL 6 0.0015
169 PSEUDOMONAS INFECTION 13 0.0015
170 PNEUMONIA 488 0.0015
171 NEPHRITIS 5 0.0015
172 FOOD POISONING 8 0.0015
173 SPINAL OSTEOARTHRITIS 13 0.0015
174 EAR DISCOMFORT 15 0.0015
175 SUBCUTANEOUS ABSCESS 7 0.0015
176 SCAR 25 0.0015
177 ACUTE RESPIRATORY FAILURE 28 0.0015
178 SCOLIOSIS 9 0.0015
179 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
180 FUNGAL INFECTION 48 0.0014
181 VITAMIN D DEFICIENCY 14 0.0014
182 MULTIPLE INJURIES 9 0.0014
183 SLEEP TERROR 6 0.0014
184 CARDIAC FAILURE CHRONIC 6 0.0014
185 PROTEIN URINE PRESENT 7 0.0014
186 GALLBLADDER DISORDER 25 0.0014
187 HORDEOLUM 6 0.0014
188 SKIN LACERATION 15 0.0014
189 ENDOCARDITIS 7 0.0014
190 COVID-19 PNEUMONIA 16 0.0014
191 CATHETERISATION CARDIAC 6 0.0014
192 TONSILLITIS 7 0.0013
193 GASTROINTESTINAL INFECTION 12 0.0013
194 PROTHROMBIN TIME PROLONGED 8 0.0013
195 SKIN INFECTION 15 0.0013
196 PRODUCT ADMINISTRATION ERROR 27 0.0013
197 BRONCHIECTASIS 9 0.0013
198 SINUS CONGESTION 18 0.0013
199 INCONTINENCE 14 0.0013
200 ABDOMINAL HERNIA 6 0.0013
201 OSTEOPOROSIS 54 0.0013
202 GASTRIC INFECTION 5 0.0013
203 GINGIVAL DISORDER 5 0.0013
204 GINGIVITIS 7 0.0013
205 HIP SURGERY 7 0.0013
206 CELLULITIS 65 0.0013
207 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
208 FLANK PAIN 12 0.0013
209 ORAL INFECTION 5 0.0013
210 VAGINAL INFECTION 6 0.0013
211 MUSCLE STRAIN 11 0.0013
212 QUALITY OF LIFE DECREASED 17 0.0013
213 FOOT FRACTURE 24 0.0013
214 RIB FRACTURE 26 0.0013
215 FURUNCLE 10 0.0013
216 ENDOMETRIOSIS 6 0.0013
217 HEART RATE ABNORMAL 7 0.0013
218 CEREBRAL ATROPHY 5 0.0013
219 LUNG INFILTRATION 11 0.0012
220 ILLNESS 128 0.0012
221 PERIORBITAL SWELLING 7 0.0012
222 TENDON DISORDER 8 0.0012
223 CHOLECYSTECTOMY 14 0.0012
224 KNEE OPERATION 12 0.0012
225 HYPERVOLAEMIA 6 0.0012
226 BACK INJURY 13 0.0012
227 CANDIDA INFECTION 20 0.0012
228 STAPHYLOCOCCAL INFECTION 39 0.0012
229 DYSLIPIDAEMIA 6 0.0012
230 BACTERIAL INFECTION 22 0.0012
231 PLEURISY 7 0.0012
232 NEPHROLITHIASIS 54 0.0012
233 CARDIAC OPERATION 10 0.0012
234 PSYCHOLOGICAL TRAUMA 10 0.0012
235 PLATELET COUNT ABNORMAL 7 0.0012
236 CARDIAC MURMUR 10 0.0012
237 GASTROOESOPHAGEAL REFLUX DISEASE 93 0.0012
238 PYELONEPHRITIS 10 0.0012
239 BONE DENSITY DECREASED 36 0.0011
240 WEIGHT FLUCTUATION 12 0.0011
241 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
242 MYOCARDIAL ISCHAEMIA 13 0.0011
243 DEFAECATION URGENCY 8 0.0011
244 DYSPNOEA EXERTIONAL 43 0.0011
245 LIMB INJURY 31 0.0011
246 MELANOCYTIC NAEVUS 5 0.0011
247 PULMONARY CONGESTION 15 0.0011
248 PARONYCHIA 5 0.0011
249 PHYSICAL DISABILITY 5 0.0011
250 DRUG ERUPTION 20 0.0011
251 PHARYNGEAL SWELLING 11 0.0011
252 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
253 RHINITIS 9 0.0011
254 STENT PLACEMENT 9 0.0011
255 IMPAIRED QUALITY OF LIFE 16 0.0011
256 LIGAMENT SPRAIN 11 0.0011
257 IRON DEFICIENCY 5 0.0011
258 NASAL CONGESTION 65 0.0011
259 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
260 PRODUCT STORAGE ERROR 96 0.0011
261 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 57 0.0011
262 CYSTIC FIBROSIS 6 0.0011
263 INTRACRANIAL PRESSURE INCREASED 6 0.0011
264 INFLUENZA 120 0.0011
265 PLATELET COUNT INCREASED 14 0.0011
266 HAEMATOCRIT DECREASED 21 0.0011
267 INFECTION 152 0.0010
268 POST-TRAUMATIC STRESS DISORDER 7 0.0010
269 MOUTH SWELLING 6 0.0010
270 POSTOPERATIVE WOUND INFECTION 7 0.0010
271 TENDONITIS 16 0.0010
272 BLOOD POTASSIUM DECREASED 31 0.0010
273 LUNG INFECTION 16 0.0010
274 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
275 HEART RATE IRREGULAR 23 0.0010
276 AFFECTIVE DISORDER 8 0.0010
277 HEPATOMEGALY 10 0.0010
278 DEEP VEIN THROMBOSIS 66 0.0010
279 PANCREATIC DISORDER 5 0.0010
280 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
281 LYMPHOEDEMA 7 0.0010
282 PULMONARY THROMBOSIS 11 0.0010
283 FACIAL PAIN 9 0.0010
284 TRICUSPID VALVE INCOMPETENCE 8 0.0010
285 GINGIVAL PAIN 8 0.0010
286 HYPERLIPIDAEMIA 12 0.0010
287 APHONIA 14 0.0010
288 EMOTIONAL DISTRESS 121 0.0010
289 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
290 BLOOD COUNT ABNORMAL 15 0.0010
291 HAND FRACTURE 7 0.0010
292 URTICARIA 165 0.0010
293 POST PROCEDURAL INFECTION 8 0.0010
294 MALNUTRITION 11 0.0010
295 TOOTH ABSCESS 10 0.0010
296 COUGH 274 0.0010
297 NEUTROPHIL COUNT INCREASED 10 0.0010
298 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
299 CYST 12 0.0010
300 OLIGURIA 6 0.0010
301 RENAL DISORDER 45 0.0010
302 EYE DISCHARGE 10 0.0010
303 LYMPHOCYTE COUNT DECREASED 17 0.0010
304 TENDERNESS 10 0.0010
305 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 46 0.0010
306 ARTERIOSCLEROSIS 9 0.0010
307 ORAL DISORDER 7 0.0010
308 COVID-19 167 0.0010
309 LOCALISED INFECTION 23 0.0010
310 GOUT 17 0.0009
311 POST PROCEDURAL HAEMORRHAGE 11 0.0009
312 SLEEP APNOEA SYNDROME 18 0.0009
313 SPLENOMEGALY 11 0.0009
314 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
315 DIVERTICULITIS 26 0.0009
316 LYMPHADENOPATHY 33 0.0009
317 HAEMOPTYSIS 26 0.0009
318 HEREDITARY ANGIOEDEMA 10 0.0009
319 SEPSIS 103 0.0009
320 BACK DISORDER 15 0.0009
321 TROPONIN INCREASED 7 0.0009
322 SINUS TACHYCARDIA 13 0.0009
323 WHEEZING 54 0.0009
324 RED BLOOD CELL COUNT DECREASED 26 0.0009
325 ABNORMAL BEHAVIOUR 36 0.0009
326 MUSCULOSKELETAL CHEST PAIN 14 0.0009
327 ANKLE FRACTURE 14 0.0009
328 DENTAL CARIES 10 0.0009
329 PERIPHERAL SWELLING 139 0.0009
330 HYPOALBUMINAEMIA 7 0.0009
331 SPINAL FRACTURE 18 0.0009
332 BRAIN INJURY 9 0.0009
333 BLOOD URINE PRESENT 17 0.0009
334 HAEMOLYTIC ANAEMIA 8 0.0009
335 PLATELET COUNT DECREASED 95 0.0009
336 COLITIS ISCHAEMIC 6 0.0009
337 METASTASES TO LYMPH NODES 6 0.0009
338 SURGERY 52 0.0009
339 OROPHARYNGEAL DISCOMFORT 8 0.0009
340 ASPARTATE AMINOTRANSFERASE INCREASED 47 0.0009
341 PRODUCT LABEL ISSUE 6 0.0009
342 THERAPY INTERRUPTED 63 0.0009
343 ASTHMA 99 0.0009
344 ONYCHOCLASIS 6 0.0009
345 RESPIRATION ABNORMAL 6 0.0009
346 POOR VENOUS ACCESS 9 0.0009
347 UROSEPSIS 8 0.0009
348 ENTEROCOLITIS 5 0.0009
349 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
350 MENTAL STATUS CHANGES 24 0.0009
351 ORAL DISCOMFORT 12 0.0009
352 CONJUNCTIVITIS 16 0.0009
353 PRODUCT ODOUR ABNORMAL 9 0.0009
354 NASOPHARYNGITIS 158 0.0009
355 ABNORMAL FAECES 7 0.0009
356 DUODENAL ULCER 6 0.0008
357 LABORATORY TEST ABNORMAL 25 0.0008
358 PRODUCT DOSE OMISSION ISSUE 249 0.0008
359 FRACTURE 16 0.0008
360 THROMBOSIS 68 0.0008
361 THYROID DISORDER 13 0.0008
362 BODY HEIGHT DECREASED 9 0.0008
363 CHEST DISCOMFORT 86 0.0008
364 IRRITABLE BOWEL SYNDROME 18 0.0008
365 ANXIETY 238 0.0008
366 RHINORRHOEA 54 0.0008
367 ORAL CANDIDIASIS 11 0.0008
368 WRIST FRACTURE 10 0.0008
369 DIARRHOEA 537 0.0008
370 PYREXIA 287 0.0008
371 TONGUE DISORDER 6 0.0008
372 DIZZINESS POSTURAL 8 0.0008
373 RESTLESS LEGS SYNDROME 15 0.0008
374 BURSITIS 10 0.0008
375 ADRENAL INSUFFICIENCY 10 0.0008
376 HYPOXIA 29 0.0008
377 WOUND INFECTION 9 0.0008
378 DYSURIA 30 0.0008
379 CARDIOMYOPATHY 12 0.0008
380 PAIN IN JAW 23 0.0008
381 PIGMENTATION DISORDER 5 0.0008
382 NERVE INJURY 9 0.0008
383 HYSTERECTOMY 7 0.0008
384 MIGRAINE 77 0.0008
385 NECK PAIN 45 0.0008
386 SNEEZING 18 0.0008
387 RESPIRATORY DISORDER 24 0.0008
388 BLOOD CALCIUM DECREASED 9 0.0008
389 HYPERKALAEMIA 28 0.0008
390 CRYING 29 0.0008
391 CARDIAC FAILURE CONGESTIVE 64 0.0008
392 CONSTIPATION 173 0.0008
393 MULTIPLE FRACTURES 13 0.0008
394 TASTE DISORDER 16 0.0008
395 PULMONARY OEDEMA 35 0.0008
396 ENTERITIS 5 0.0008
397 PRODUCT DISPENSING ERROR 17 0.0008
398 DEVICE RELATED INFECTION 12 0.0008
399 HAEMATOCHEZIA 43 0.0008
400 PERICARDIAL EFFUSION 18 0.0008
401 OSTEOMYELITIS 14 0.0008
402 INTENTIONAL DOSE OMISSION 22 0.0008
403 HERPES SIMPLEX 5 0.0008
404 BONE DISORDER 14 0.0008
405 NEUROPATHY PERIPHERAL 73 0.0008
406 GASTROINTESTINAL INFLAMMATION 6 0.0008
407 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
408 TRANSFUSION 8 0.0008
409 HYPOGAMMAGLOBULINAEMIA 5 0.0008
410 CHILLS 89 0.0008
411 NERVE COMPRESSION 7 0.0008
412 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
413 RENAL PAIN 8 0.0008
414 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
415 PRODUCT DISTRIBUTION ISSUE 7 0.0008
416 APPETITE DISORDER 5 0.0008
417 CHROMATURIA 17 0.0008
418 HEPATIC STEATOSIS 14 0.0008
419 APPENDICITIS 7 0.0007
420 LOWER RESPIRATORY TRACT INFECTION 34 0.0007
421 OROPHARYNGEAL PAIN 69 0.0007
422 BREAST MASS 5 0.0007
423 LACERATION 7 0.0007
424 BLOOD SODIUM DECREASED 14 0.0007
425 INJURY 52 0.0007
426 WHITE BLOOD CELL COUNT DECREASED 80 0.0007
427 IMMUNODEFICIENCY 11 0.0007
428 OEDEMA 40 0.0007
429 DECUBITUS ULCER 6 0.0007
430 HEAD DISCOMFORT 13 0.0007
431 NO ADVERSE EVENT 133 0.0007
432 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
433 BONE LOSS 11 0.0007
434 CARDIOMEGALY 9 0.0007
435 POST PROCEDURAL COMPLICATION 14 0.0007
436 HAIR DISORDER 6 0.0007
437 FLUID RETENTION 37 0.0007
438 HEAD INJURY 23 0.0007
439 EYE SWELLING 27 0.0007
440 TOOTH FRACTURE 8 0.0007
441 HYPERCHOLESTEROLAEMIA 7 0.0007
442 ACUTE CORONARY SYNDROME 6 0.0007
443 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
444 ILEUS 9 0.0007
445 HAIR COLOUR CHANGES 9 0.0007
446 LARGE INTESTINE PERFORATION 5 0.0007
447 DEHYDRATION 96 0.0007
448 ATRIAL FIBRILLATION 70 0.0007
449 LEUKOCYTOSIS 13 0.0007
450 AUTOIMMUNE DISORDER 7 0.0007
451 HYPERSENSITIVITY 133 0.0007
452 DECREASED APPETITE 166 0.0007
453 ORAL PAIN 16 0.0007
454 HAEMODIALYSIS 6 0.0007
455 COELIAC DISEASE 7 0.0007
456 DEVICE OCCLUSION 10 0.0007
457 URINARY INCONTINENCE 21 0.0007
458 EPISTAXIS 53 0.0007
459 OSTEOARTHRITIS 30 0.0007
460 HEART RATE INCREASED 70 0.0007
461 VITAMIN D DECREASED 6 0.0007
462 BRAIN FOG 11 0.0007
463 IMPAIRED WORK ABILITY 15 0.0007
464 ROTATOR CUFF SYNDROME 9 0.0007
465 RESPIRATORY FAILURE 51 0.0007
466 NEURALGIA 17 0.0007
467 MUSCULOSKELETAL DISCOMFORT 12 0.0007
468 GRAFT VERSUS HOST DISEASE 5 0.0007
469 BLOOD MAGNESIUM DECREASED 6 0.0007
470 HIATUS HERNIA 9 0.0007
471 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
472 OXYGEN SATURATION DECREASED 39 0.0007
473 EMPHYSEMA 7 0.0007
474 HAEMOGLOBIN DECREASED 71 0.0007
475 LIP SWELLING 23 0.0007
476 RENAL IMPAIRMENT 58 0.0007
477 ELECTROLYTE IMBALANCE 8 0.0007
478 DEAFNESS 18 0.0007
479 URINE OUTPUT DECREASED 6 0.0007
480 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
481 MAJOR DEPRESSION 5 0.0007
482 ALANINE AMINOTRANSFERASE INCREASED 42 0.0007
483 MOUTH HAEMORRHAGE 5 0.0007
484 THERAPY CESSATION 35 0.0007
485 SARS-COV-2 TEST POSITIVE 9 0.0007
486 OEDEMA PERIPHERAL 83 0.0007
487 TEMPERATURE INTOLERANCE 7 0.0007
488 ANAEMIA 129 0.0007
489 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
490 SEIZURE 78 0.0007
491 BLOOD IRON DECREASED 8 0.0007
492 FEELING DRUNK 5 0.0007
493 CATARACT 40 0.0007
494 HYPOKALAEMIA 31 0.0007
495 HEPATIC FUNCTION ABNORMAL 25 0.0007
496 FULL BLOOD COUNT ABNORMAL 7 0.0007
497 RASH 288 0.0007
498 SKIN DISORDER 22 0.0007
499 STOMATITIS 40 0.0007
500 PRODUCT AVAILABILITY ISSUE 15 0.0007
501 HYPOTHYROIDISM 21 0.0007
502 BLOOD UREA INCREASED 11 0.0007
503 RASH GENERALISED 17 0.0007
504 CONTUSION 63 0.0007
505 PULMONARY EMBOLISM 62 0.0007
506 ABDOMINAL DISTENSION 68 0.0007
507 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
508 IRON DEFICIENCY ANAEMIA 6 0.0006
509 SMALL INTESTINAL OBSTRUCTION 8 0.0006
510 DYSPHONIA 38 0.0006
511 GASTROINTESTINAL DISORDER 58 0.0006
512 BIPOLAR DISORDER 7 0.0006
513 SEPTIC SHOCK 28 0.0006
514 BASAL CELL CARCINOMA 10 0.0006
515 CHOLELITHIASIS 21 0.0006
516 SWOLLEN TONGUE 20 0.0006
517 NEUTROPHIL COUNT DECREASED 26 0.0006
518 POISONING 8 0.0006
519 COLITIS 24 0.0006
520 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
521 MUSCLE ATROPHY 8 0.0006
522 GASTRIC ULCER 12 0.0006
523 ULCER 10 0.0006
524 HYPERSOMNIA 18 0.0006
525 WEIGHT DECREASED 175 0.0006
526 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
527 HIP FRACTURE 20 0.0006
528 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
529 ANOSMIA 9 0.0006
530 ABDOMINAL DISCOMFORT 104 0.0006
531 MUSCLE TIGHTNESS 10 0.0006
532 GASTROENTERITIS 9 0.0006
533 DYSSTASIA 18 0.0006
534 PAIN 378 0.0006
535 HAEMORRHOIDS 12 0.0006
536 NODULE 8 0.0006
537 PRODUCT DOSE OMISSION 40 0.0006
538 BACK PAIN 142 0.0006
539 MUSCLE SPASMS 112 0.0006
540 HERPES ZOSTER 35 0.0006
541 SWELLING 57 0.0006
542 LIVER DISORDER 27 0.0006
543 SHOCK 14 0.0006
544 TOOTHACHE 11 0.0006
545 SKIN HAEMORRHAGE 9 0.0006
546 ACTIVITIES OF DAILY LIVING IMPAIRED 12 0.0006
547 FATIGUE 471 0.0006
548 BLADDER DISORDER 6 0.0006
549 URINARY RETENTION 20 0.0006
550 CYTOKINE RELEASE SYNDROME 12 0.0006
551 ANAPHYLACTIC REACTION 33 0.0006
552 FALL 198 0.0006
553 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
554 ABDOMINAL PAIN 138 0.0006
555 ASTHENIA 223 0.0006
556 BLOOD BILIRUBIN INCREASED 16 0.0006
557 PLEURAL EFFUSION 36 0.0006
558 DRUG DISPENSING ERROR 9 0.0006
559 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
560 SLUGGISHNESS 6 0.0006
561 HYPOPHAGIA 15 0.0006
562 HAEMATURIA 20 0.0006
563 DYSPNOEA 329 0.0006
564 UNRESPONSIVE TO STIMULI 15 0.0006
565 PALPITATIONS 68 0.0006
566 MULTI-ORGAN FAILURE 10 0.0006
567 NOCTURIA 7 0.0006
568 FIBROMYALGIA 14 0.0006
569 LOWER LIMB FRACTURE 11 0.0006
570 WOUND 16 0.0006
571 METASTASES TO LIVER 10 0.0006
572 HERNIA 11 0.0006
573 GAIT INABILITY 19 0.0006
574 SPINAL OPERATION 7 0.0006
575 BLOOD CREATININE INCREASED 37 0.0006
576 MUSCLE TWITCHING 13 0.0006
577 VOMITING 265 0.0006
578 APHASIA 17 0.0006
579 TOOTH EXTRACTION 7 0.0006
580 AGEUSIA 14 0.0006
581 SECRETION DISCHARGE 7 0.0006
582 ANGINA PECTORIS 16 0.0006
583 INFUSION RELATED REACTION 37 0.0006
584 HYPOACUSIS 24 0.0006
585 SKIN CANCER 12 0.0006
586 HALLUCINATION 42 0.0006
587 HYPOGLYCAEMIA 27 0.0006
588 DISABILITY 11 0.0006
589 LETHARGY 32 0.0006
590 CHEST PAIN 103 0.0006
591 ANAL INCONTINENCE 5 0.0006
592 INSOMNIA 148 0.0006
593 DRY MOUTH 45 0.0006
594 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
595 ABDOMINAL PAIN LOWER 14 0.0006
596 HOSPITALISATION 85 0.0006
597 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
598 GASTROINTESTINAL HAEMORRHAGE 46 0.0005
599 MOOD ALTERED 15 0.0005
600 ABDOMINAL PAIN UPPER 113 0.0005
601 PATHOGEN RESISTANCE 5 0.0005
602 DYSPHAGIA 52 0.0005
603 INFLUENZA LIKE ILLNESS 45 0.0005
604 FEEDING DISORDER 11 0.0005
605 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
606 BLOOD PRESSURE FLUCTUATION 13 0.0005
607 HEART RATE DECREASED 19 0.0005
608 COAGULOPATHY 9 0.0005
609 PAIN IN EXTREMITY 159 0.0005
610 BODY TEMPERATURE INCREASED 11 0.0005
611 HEADACHE 338 0.0005
612 DIPLOPIA 14 0.0005
613 PULMONARY MASS 8 0.0005
614 RASH PAPULAR 12 0.0005
615 RASH PRURITIC 29 0.0005
616 DIARRHOEA HAEMORRHAGIC 5 0.0005
617 HYPOTENSION 107 0.0005
618 GASTRITIS 14 0.0005
619 DEPRESSION 121 0.0005
620 HOT FLUSH 40 0.0005
621 ENCEPHALOPATHY 13 0.0005
622 UNEVALUABLE EVENT 40 0.0005
623 ABASIA 13 0.0005
624 SCAB 6 0.0005
625 GASTRIC DISORDER 18 0.0005
626 SLEEP DISORDER 37 0.0005
627 HAIR TEXTURE ABNORMAL 7 0.0005
628 PANIC ATTACK 19 0.0005
629 PHARYNGEAL OEDEMA 8 0.0005
630 PRODUCT TASTE ABNORMAL 7 0.0005
631 MADAROSIS 6 0.0005
632 ORTHOSTATIC HYPOTENSION 9 0.0005
633 DYSKINESIA 21 0.0005
634 EATING DISORDER 11 0.0005
635 INTERSTITIAL LUNG DISEASE 25 0.0005
636 DELUSION 8 0.0005
637 EJECTION FRACTION DECREASED 8 0.0005
638 ARTHRALGIA 214 0.0005
639 NAUSEA 406 0.0005
640 THROAT IRRITATION 23 0.0005
641 BLOOD PRESSURE DECREASED 34 0.0005
642 COLD SWEAT 9 0.0005
643 SKIN LESION 14 0.0005
644 PERIPHERAL COLDNESS 7 0.0005
645 ACUTE MYOCARDIAL INFARCTION 15 0.0005
646 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
647 INFLAMMATION 26 0.0005
648 CHOLECYSTITIS 6 0.0005
649 BLOOD PRESSURE ABNORMAL 10 0.0005
650 RASH ERYTHEMATOUS 24 0.0005
651 ABSCESS 8 0.0005
652 DRY EYE 25 0.0005
653 TINNITUS 23 0.0005
654 OVARIAN CYST 5 0.0005
655 AGGRESSION 25 0.0005
656 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
657 CORONARY ARTERY DISEASE 15 0.0005
658 TOOTH DISORDER 11 0.0005
659 RASH MACULO-PAPULAR 11 0.0005
660 FLATULENCE 28 0.0005
661 DRY THROAT 5 0.0005
662 DISCOMFORT 30 0.0005
663 GAIT DISTURBANCE 94 0.0005
664 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
665 FEELING ABNORMAL 117 0.0005
666 OSTEONECROSIS 16 0.0005
667 MOBILITY DECREASED 35 0.0005
668 DRUG LEVEL INCREASED 8 0.0005
669 JAUNDICE 13 0.0005
670 ARTHRITIS 38 0.0005
671 MIDDLE INSOMNIA 9 0.0005
672 BLISTER 27 0.0005
673 THROAT TIGHTNESS 13 0.0005
674 PULMONARY HYPERTENSION 10 0.0005
675 POLLAKIURIA 20 0.0005
676 PETECHIAE 5 0.0005
677 PRURITUS 184 0.0005
678 DRUG-INDUCED LIVER INJURY 15 0.0005
679 PALLOR 13 0.0005
680 PNEUMONITIS 13 0.0005
681 MUSCULOSKELETAL PAIN 25 0.0005
682 FOLLICULITIS 5 0.0005
683 ASCITES 14 0.0005
684 PROTEINURIA 9 0.0005
685 ANGER 16 0.0005
686 JOINT DISLOCATION 5 0.0005
687 MUSCULOSKELETAL DISORDER 9 0.0005
688 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 85 0.0005
689 BLOOD PRESSURE INCREASED 72 0.0005
690 BURNING SENSATION 33 0.0005
691 INTRAOCULAR PRESSURE INCREASED 6 0.0005
692 RETCHING 10 0.0005
693 PROCEDURAL PAIN 13 0.0005
694 JOINT INJURY 10 0.0005
695 HYPOAESTHESIA 70 0.0005
696 DYSPEPSIA 46 0.0005
697 HYPERGLYCAEMIA 17 0.0005
698 MUSCULAR WEAKNESS 53 0.0005
699 RESTLESSNESS 17 0.0005
700 HYPOAESTHESIA ORAL 7 0.0005
701 SKIN ULCER 12 0.0005
702 PARANOIA 8 0.0005
703 JOINT SWELLING 56 0.0005
704 BALANCE DISORDER 40 0.0005
705 NIGHTMARE 16 0.0005
706 SWELLING FACE 30 0.0005
707 SKIN FISSURES 9 0.0005
708 VERTIGO 28 0.0005
709 MEMORY IMPAIRMENT 63 0.0005
710 RASH MACULAR 16 0.0005
711 ASPIRATION 5 0.0005
712 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
713 IMMUNE SYSTEM DISORDER 6 0.0005
714 HEPATIC ENZYME INCREASED 31 0.0005
715 GASTROINTESTINAL PAIN 5 0.0005
716 MALAISE 199 0.0005
717 FEBRILE NEUTROPENIA 30 0.0005
718 FOOT DEFORMITY 5 0.0005
719 MALIGNANT MELANOMA 6 0.0004
720 CONDITION AGGRAVATED 136 0.0004
721 DIABETES MELLITUS 34 0.0004
722 PANCREATITIS ACUTE 10 0.0004
723 PRODUCT USE COMPLAINT 7 0.0004
724 DIZZINESS 221 0.0004
725 MITRAL VALVE INCOMPETENCE 5 0.0004
726 PNEUMONIA ASPIRATION 11 0.0004
727 PREMATURE DELIVERY 7 0.0004
728 OBESITY 7 0.0004
729 SPEECH DISORDER 23 0.0004
730 TACHYCARDIA 39 0.0004
731 CARDIAC DISORDER 41 0.0004
732 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
733 MENTAL DISORDER 19 0.0004
734 PSORIASIS 57 0.0004
735 PLASMA CELL MYELOMA 17 0.0004
736 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
737 SKIN DISCOLOURATION 20 0.0004
738 RESPIRATORY DISTRESS 12 0.0004
739 NIGHT SWEATS 14 0.0004
740 METASTASES TO LUNG 5 0.0004
741 HUNGER 6 0.0004
742 COORDINATION ABNORMAL 6 0.0004
743 MYALGIA 73 0.0004
744 CARPAL TUNNEL SYNDROME 6 0.0004
745 BLOOD TEST ABNORMAL 6 0.0004
746 HYPERHIDROSIS 55 0.0004
747 BONE PAIN 25 0.0004
748 HYPONATRAEMIA 24 0.0004
749 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
750 TREATMENT NONCOMPLIANCE 23 0.0004
751 LIVER FUNCTION TEST INCREASED 9 0.0004
752 PARALYSIS 6 0.0004
753 MACULAR DEGENERATION 5 0.0004
754 PANCREATITIS 22 0.0004
755 HYPERTENSION 88 0.0004
756 GLAUCOMA 8 0.0004
757 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
758 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14 0.0004
759 HYPOKINESIA 6 0.0004
760 NO THERAPEUTIC RESPONSE 5 0.0004
761 ACCIDENTAL OVERDOSE 15 0.0004
762 CEREBRAL INFARCTION 10 0.0004
763 MENORRHAGIA 8 0.0004
764 FREQUENT BOWEL MOVEMENTS 11 0.0004
765 MOVEMENT DISORDER 13 0.0004
766 ERYTHEMA 83 0.0004
767 ALOPECIA 79 0.0004
768 GLOSSODYNIA 9 0.0004
769 LACTIC ACIDOSIS 13 0.0004
770 CARDIAC ARREST 33 0.0004
771 IRRITABILITY 24 0.0004
772 HEPATIC FAILURE 12 0.0004
773 BRAIN OEDEMA 5 0.0004
774 RECTAL HAEMORRHAGE 17 0.0004
775 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
776 DEVICE FAILURE 6 0.0004
777 INJECTION SITE IRRITATION 5 0.0004
778 EYE PAIN 22 0.0004
779 TARDIVE DYSKINESIA 11 0.0004
780 EMOTIONAL DISORDER 12 0.0004
781 EYE PRURITUS 13 0.0004
782 TYPE 2 DIABETES MELLITUS 13 0.0004
783 HAEMATOMA 10 0.0004
784 TOOTH LOSS 8 0.0004
785 PELVIC PAIN 7 0.0004
786 ACUTE MYELOID LEUKAEMIA 6 0.0004
787 NERVOUS SYSTEM DISORDER 12 0.0004
788 PRODUCT USE ISSUE 72 0.0004
789 DERMATITIS 8 0.0004
790 JOINT STIFFNESS 10 0.0004
791 TREMOR 63 0.0004
792 DERMATITIS ATOPIC 20 0.0004
793 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
794 PNEUMOTHORAX 6 0.0004
795 RENAL FAILURE ACUTE 16 0.0004
796 PANCYTOPENIA 21 0.0004
797 PHOTOPHOBIA 7 0.0004
798 SOMNOLENCE 74 0.0004
799 SKIN EXFOLIATION 31 0.0004
800 FEELING JITTERY 7 0.0004
801 ACUTE HEPATIC FAILURE 5 0.0004
802 PULMONARY FIBROSIS 7 0.0004
803 LACRIMATION INCREASED 11 0.0004
804 COGNITIVE DISORDER 17 0.0004
805 VENTRICULAR TACHYCARDIA 6 0.0004
806 PHOTOSENSITIVITY REACTION 6 0.0004
807 VISUAL IMPAIRMENT 45 0.0004
808 ECZEMA 19 0.0004
809 RESPIRATORY ARREST 10 0.0004
810 WEIGHT INCREASED 81 0.0004
811 CYTOMEGALOVIRUS INFECTION 6 0.0004
812 HYPOMAGNESAEMIA 5 0.0004
813 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
814 ROAD TRAFFIC ACCIDENT 15 0.0004
815 DISEASE RECURRENCE 17 0.0004
816 PERICARDITIS 6 0.0004
817 VISION BLURRED 49 0.0004
818 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
819 ADVERSE DRUG REACTION 32 0.0004
820 BLINDNESS UNILATERAL 5 0.0004
821 DRUG INTERACTION 56 0.0004
822 UPPER LIMB FRACTURE 7 0.0004
823 SYNCOPE 35 0.0003
824 PRODUCT USE IN UNAPPROVED INDICATION 86 0.0003
825 LUNG DISORDER 17 0.0003
826 DISEASE PROGRESSION 41 0.0003
827 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
828 MYELODYSPLASTIC SYNDROME 5 0.0003
829 MOOD SWINGS 11 0.0003
830 INTESTINAL OBSTRUCTION 13 0.0003
831 HAEMORRHAGE 36 0.0003
832 METABOLIC ACIDOSIS 11 0.0003
833 DEATH 295 0.0003
834 NEUROTOXICITY 6 0.0003
835 EOSINOPHILIA 6 0.0003
836 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
837 ANGIOEDEMA 15 0.0003
838 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
839 OFF LABEL USE 296 0.0003
840 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
841 OCULAR HYPERAEMIA 16 0.0003
842 PRODUCT PRESCRIBING ERROR 8 0.0003
843 COLON CANCER 5 0.0003
844 EYE DISORDER 11 0.0003
845 KNEE ARTHROPLASTY 7 0.0003
846 EXPIRED PRODUCT ADMINISTERED 11 0.0003
847 MENTAL IMPAIRMENT 8 0.0003
848 ILL-DEFINED DISORDER 20 0.0003
849 PRESYNCOPE 8 0.0003
850 FLUSHING 33 0.0003
851 PARAESTHESIA 51 0.0003
852 CARDIAC FAILURE 26 0.0003
853 BLOOD GLUCOSE INCREASED 61 0.0003
854 LIMB DISCOMFORT 10 0.0003
855 FEMUR FRACTURE 10 0.0003
856 THINKING ABNORMAL 6 0.0003
857 BLOOD CHOLESTEROL INCREASED 15 0.0003
858 CONFUSIONAL STATE 52 0.0003
859 MYOCARDIAL INFARCTION 56 0.0003
860 PSORIATIC ARTHROPATHY 13 0.0003
861 HEPATIC CIRRHOSIS 6 0.0003
862 DYSARTHRIA 12 0.0003
863 CYANOSIS 5 0.0003
864 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
865 HYPOCALCAEMIA 6 0.0003
866 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
867 CARDIOVASCULAR DISORDER 8 0.0003
868 COLITIS ULCERATIVE 14 0.0003
869 THROMBOCYTOPENIA 35 0.0003
870 CEREBROVASCULAR ACCIDENT 53 0.0003
871 EYE IRRITATION 18 0.0003
872 HEPATITIS 8 0.0003
873 DYSTONIA 6 0.0003
874 BLOOD POTASSIUM INCREASED 5 0.0003
875 ORAL HERPES 6 0.0003
876 NERVOUSNESS 16 0.0003
877 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
878 IMPAIRED HEALING 10 0.0003
879 LOSS OF CONSCIOUSNESS 39 0.0003
880 DISORIENTATION 12 0.0003
881 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
882 INJECTION SITE SWELLING 23 0.0003
883 AGITATION 22 0.0003
884 PAIN OF SKIN 8 0.0003
885 FACE OEDEMA 5 0.0003
886 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
887 EXPOSURE DURING PREGNANCY 18 0.0003
888 DELIRIUM 10 0.0003
889 CARDIO-RESPIRATORY ARREST 12 0.0003
890 HALLUCINATION, VISUAL 6 0.0003
891 BRADYCARDIA 15 0.0003
892 DYSGEUSIA 21 0.0003
893 PRURITUS GENERALISED 6 0.0003
894 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
895 GENERAL PHYSICAL HEALTH DETERIORATION 32 0.0003
896 NEEDLE ISSUE 8 0.0003
897 ARRHYTHMIA 13 0.0003
898 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
899 DRUG DOSE OMISSION 45 0.0003
900 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
901 VISUAL ACUITY REDUCED 9 0.0003
902 BLOOD GLUCOSE ABNORMAL 5 0.0003
903 DRY SKIN 36 0.0003
904 LUNG NEOPLASM MALIGNANT 11 0.0003
905 THERAPY NON-RESPONDER 12 0.0003
906 RHEUMATOID ARTHRITIS 30 0.0003
907 WITHDRAWAL SYNDROME 11 0.0003
908 FEELING HOT 16 0.0003
909 UNDERDOSE 19 0.0003
910 DISTURBANCE IN ATTENTION 14 0.0003
911 ERUCTATION 5 0.0003
912 CHOKING 5 0.0003
913 ABNORMAL DREAMS 7 0.0003
914 ARTHROPATHY 14 0.0003
915 FEELING COLD 7 0.0003
916 CEREBRAL HAEMORRHAGE 9 0.0003
917 MUSCULOSKELETAL STIFFNESS 22 0.0003
918 DEMENTIA 7 0.0003
919 BLOOD GLUCOSE DECREASED 12 0.0002
920 DEVICE BREAKAGE 10 0.0002
921 DEPRESSED MOOD 13 0.0002
922 NEUTROPENIA 33 0.0002
923 EXTRAPYRAMIDAL DISORDER 6 0.0002
924 INCORRECT DOSE ADMINISTERED 55 0.0002
925 LIVER FUNCTION TEST ABNORMAL 7 0.0002
926 NEOPLASM MALIGNANT 16 0.0002
927 INTENTIONAL DRUG MISUSE 5 0.0002
928 DRUG INTOLERANCE 23 0.0002
929 MOUTH ULCERATION 5 0.0002
930 MEDICATION ERROR 13 0.0002
931 ERECTILE DYSFUNCTION 6 0.0002
932 NEOPLASM PROGRESSION 8 0.0002
933 DRUG ADMINISTRATION ERROR 7 0.0002
934 DRUG INEFFECTIVE 299 0.0002
935 INJECTION SITE PRURITUS 15 0.0002
936 BLINDNESS 9 0.0002
937 C-REACTIVE PROTEIN INCREASED 8 0.0002
938 ADVERSE EVENT 20 0.0002
939 INJECTION SITE MASS 8 0.0002
940 AMNESIA 14 0.0002
941 PRODUCT QUALITY ISSUE 29 0.0002
942 ACNE 16 0.0002
943 MULTIPLE SCLEROSIS 10 0.0002
944 INTENTIONAL PRODUCT MISUSE 18 0.0002
945 DRUG EFFECT DECREASED 11 0.0002
946 LIVER INJURY 5 0.0002
947 LEUKOPENIA 10 0.0002
948 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
949 SUICIDAL IDEATION 18 0.0002
950 DRUG EFFECT INCOMPLETE 7 0.0002
951 CONVULSION 11 0.0002
952 INJECTION SITE REACTION 13 0.0002
953 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
954 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
955 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
956 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
957 SKIN IRRITATION 8 0.0002
958 PANCREATIC CARCINOMA 5 0.0002
959 EXTRA DOSE ADMINISTERED 7 0.0002
960 TREATMENT FAILURE 14 0.0002
961 MYELOSUPPRESSION 6 0.0002
962 EPILEPSY 5 0.0002
963 INJECTION SITE RASH 5 0.0002
964 DEVICE LEAKAGE 7 0.0002
965 COMPLETED SUICIDE 13 0.0002
966 INJECTION SITE PAIN 47 0.0002
967 INJECTION SITE ERYTHEMA 19 0.0002
968 ABORTION SPONTANEOUS 6 0.0001
969 TOXICITY TO VARIOUS AGENTS 25 0.0001
970 DEVICE ISSUE 13 0.0001
971 SKIN BURNING SENSATION 10 0.0001
972 PRODUCT SUBSTITUTION ISSUE 8 0.0001
973 SUICIDE ATTEMPT 8 0.0001
974 BREAST CANCER 12 0.0001
975 DEVICE MALFUNCTION 9 0.0001
976 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
977 RENAL CANCER 6 0.0001
978 INJECTION SITE BRUISING 10 0.0001
979 OVERDOSE 27 0.0001
980 DEVICE DISLOCATION 5 0.0001
981 INTENTIONAL OVERDOSE 7 0.0001
982 COMA 5 0.0001
983 INJECTION SITE HAEMORRHAGE 8 0.0001
984 DRUG DEPENDENCE 16 0.0001
985 PROSTATE CANCER 8 0.0001
986 THERAPEUTIC RESPONSE DECREASED 6 0.0001
987 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
988 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
990 DEPENDENCE 5 0.0001
991 DRUG WITHDRAWAL SYNDROME 6 0.0001